share_log

NexImmune | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

NexImmune | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

NexImmune | 25-NSE：由交易所申報的註銷已到期、已贖回、已兌付證券的通知
美股SEC公告 ·  09/06 19:45

牛牛AI助理已提取核心訊息

NexImmune, Inc., listed on the Nasdaq Stock Market LLC, is set to be removed from listing effective at the opening of the trading session on September 16, 2024. The decision for delisting came after the Nasdaq Staff concluded that NexImmune no longer met the requirements for listing as per Listing Rule 5101. The company was initially notified of this determination on November 30, 2023. NexImmune appealed the decision, and on March 11, 2024, the Listing Qualifications Hearings Panel allowed the company to remain listed, contingent on meeting certain milestones. However, NexImmune failed to meet these conditions, leading to a final decision to delist on July 10, 2024. Trading of the company's securities was suspended on July 12, 2024. NexImmune did not further appeal, and the delisting determination became final on August 26, 2024.
NexImmune, Inc., listed on the Nasdaq Stock Market LLC, is set to be removed from listing effective at the opening of the trading session on September 16, 2024. The decision for delisting came after the Nasdaq Staff concluded that NexImmune no longer met the requirements for listing as per Listing Rule 5101. The company was initially notified of this determination on November 30, 2023. NexImmune appealed the decision, and on March 11, 2024, the Listing Qualifications Hearings Panel allowed the company to remain listed, contingent on meeting certain milestones. However, NexImmune failed to meet these conditions, leading to a final decision to delist on July 10, 2024. Trading of the company's securities was suspended on July 12, 2024. NexImmune did not further appeal, and the delisting determination became final on August 26, 2024.
納斯達克股票交易市場的上市公司NexImmune, Inc.將於2024年9月16日開盤交易時被除牌。除牌決定是因爲納斯達克工作人員認定NexImmune不再符合5101號上市規則的要求。公司最初於2023年11月30日收到了這一決定的通知。NexImmune對此決定提出上訴，於2024年3月11日，上市資格聽證會允許該公司繼續上市，但前提是滿足一定里程碑。然而，NexImmune未能達到這些條件，導致於2024年7月10日做出最終決定除牌。該公司證券的交易於2024年7月12日停牌。NexImmune沒有進一步上訴，除牌決定於2024年8月26日變爲最終。
納斯達克股票交易市場的上市公司NexImmune, Inc.將於2024年9月16日開盤交易時被除牌。除牌決定是因爲納斯達克工作人員認定NexImmune不再符合5101號上市規則的要求。公司最初於2023年11月30日收到了這一決定的通知。NexImmune對此決定提出上訴，於2024年3月11日，上市資格聽證會允許該公司繼續上市，但前提是滿足一定里程碑。然而，NexImmune未能達到這些條件，導致於2024年7月10日做出最終決定除牌。該公司證券的交易於2024年7月12日停牌。NexImmune沒有進一步上訴，除牌決定於2024年8月26日變爲最終。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間